An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain.

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...